Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new institute for nanoscience research is to open in Oxford thanks to a $10 million gift from The Kavli Foundation.

Biochemistry Building Completion

The new Kavli Institute for NanoScience Discovery (Kavli INSD) at Oxford will be a unique combination of structural biology with world-leading biochemistry, pathology, chemistry, physics, physiology and engineering. Based in a new building at the centre of Oxford’s Science Area site, it will house more than 40 faculty and 400 students, postdocs and research staff.

It will be the 20th Kavli Institute globally and The Kavli Foundation’s fifth institute in nanoscience when it opens its doors in January 2021.

Professor Gavin Screaton, Head of Oxford University’s Medical Sciences Division, said: “Oxford has a rich tradition as a research-driven university and the addition of a Kavli Institute will enhance that collaborative nature that helps us to deliver exceptional education, to carry out world-leading research, and to make significant contributions to society – locally, nationally and internationally.

'The multidisciplinary nature of nanoscience broadens the possibilities for discoveries, which can translate into innovations that can benefit economies and humanity worldwide, such as the development of the gene-editing technology CRISPR.'

The full story is available on the University of Oxford website

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.